Labelled fibrinogen receptor antagonists, the use thereof and processes for preparing them
The invention relates to new labelled fibrinogen receptor antagonists which have an affinity for the receptor which is comparable to or greater than that of .sup.125 I-fibrinogen and whose binding is not disrupted by foreign proteins.
Latest Dr. Karl Thomae, GmbH Patents:
- Modified amino acids, pharmaceuticals containing these compounds and method for their production
- Modified amino acids, pharmaceuticals containing these compounds and method for their production
- Modified aminoacids, pharmaceuticals containing these compounds and method for their production
- Sampling system for use in the analysis of biological processes
- Strong homologous promoter obtained from hamsters
Claims
1. A method of testing binding capability of a chemical substance to fibrinogen receptors which comprises combining a chemical substance to be tested with an amidine of formula
- R.sub.a represents a 4-amidinophenyl group, and
- R.sub.b represents an HOOC--D--C--B--A-- group, wherein
- A represents an optionally methoxy-substituted phenylene group,
- B represents a methyleneoxy group bound to the group A via the oxygen atom,
- C represents a pyrrolidin-di-yl or pyrrolidinon-di-yl group substituted by the group R.sub.3 at the nitrogen atom, and
- D represents a bond or a methylene or ethylene group, whilst
- R.sub.3 represents a hydrogen atom, a 3-phenylpropyl, acetyl, methanesulphonyl or pyrrolidinocarbonylmethyl group,
2. An amidine of formula
- R.sub.a represents a 4-amidinophenyl group, and
- R.sub.b represents an HOOC--D--C--B--A-- group, wherein
- A represents an optionally methoxy-substituted phenylene group,
- B represents a methyleneoxy group bound to the group A via the oxygen atom,
- C represents a pyrrolidin-di-yl or pyrrolidinon-di-yl group substituted by the group R.sub.3 at the nitrogen atom, and
- D represents a bond or a methylene or ethylene group, whilst
- R.sub.3 represents a hydrogen atom, a 3-phenylpropyl, acetyl, methanesulphonyl or pyrrolidinocarbonylmethyl group,
3. The fibrinogen receptor antagonist as recited in claim 2,
- R.sub.a represents a 4-amidino-phenyl group,
- R.sub.b represents a phenyl group which is substituted in the 4-position by a 4-carboxymethyl-pyrrolidin-2-yl-methyloxy or 3-carboxymethyl-pyrrolidin-2-on-5-yl-methyloxy group, whilst in the 1-position each pyrrolidine moiety may be substituted by an acetyl or methanesulphonyl group and the pyrrolidinone moiety may be substituted by a 3-phenyl-propyl or pyrrolidinocarbonylmethyl group,
4. The fibrinogen receptor antagonist as recited in claim 2, further characterized in that an aromatic hydrogen atom is replaced by tritium.
9. A method for determining concentration of fibrinogen antagonists in a mixture of various chemical substances which comprises mixing a tritium labeled amidine of formula
- R.sub.a represents a 4-amidinophenyl group, and
- R.sub.b represents an HOOC--D--C--B--A-- group, wherein
- A represents an optionally methoxy-substituted phenylene group,
- B represents a methyleneoxy group bound to the group A via the oxygen atom,
- C represents a pyrrolidin-di-yl or pyrrolidinon-di-yl group substituted by the group R.sub.3 at the nitrogen atom, and
- D represents a bond or a methylene or ethylene group, whilst
- R.sub.3 represents a hydrogen atom, a 3-phenylpropyl, acetyl, methanesulphonyl or pyrrolidinocarbonylmethyl group,
10. The method of claim 9 wherein the mixture comprises albumin or other body fluids.
5455348 | October 3, 1995 | Austel et al. |
5463071 | October 31, 1995 | Himmelsbach et al. |
5478942 | December 26, 1995 | Himmelsbach et al. |
0372486 | December 1989 | EPX |
0381033 | January 1990 | EPX |
0503548 | March 1992 | EPX |
0483667 | May 1992 | EPX |
0496378 | July 1992 | EPX |
0525629 | July 1992 | EPX |
0528369 | February 1993 | EPX |
0381033 | August 1993 | EPX |
4129603 | September 1991 | DEX |
4134467 | October 1991 | DEX |
- "Low Molecular Weight, non-Peptide Fibrinogen Receptor Antagonists" J. Med. Chem. May 4, 1992, 35, 4393-4407.
Type: Grant
Filed: May 23, 1995
Date of Patent: Oct 14, 1997
Assignee: Dr. Karl Thomae, GmbH (Biberach an der Riss)
Inventors: Johannes Weisenberger (Biberach), Hans-Dieter Schubert (Biberach), Gunter Linz (Mittelbiberach), Karl-Heinz Switek (Biberach), Frank Himmelsbach (Mittelbiberach)
Primary Examiner: Matthew V. Grumbling
Attorneys: R. P. Raymond, A. R. Stempel, M-E. M. Devlin
Application Number: 8/477,667
International Classification: C07D20726; C07D207263;